Senior Clinical Outcomes Assessment

Vor 6 Tagen

Basel, Basel-Stadt, Schweiz gloor & lang Pharma and Biotech Recruiting Vollzeit
pb12-month temporary assignment | Basel | Global Pharmaceutical Company /b /ppFor a global pharmaceutical company in Basel, we are looking for an experienced bSenior Clinical Outcomes Assessment (COA/PRO) Manager /b with strong expertise in patient-centered outcomes research. /ppThis is a highly visible scientific and strategic role at the interface of bclinical development, regulatory affairs, HEOR and market access. /b You will shape COA strategies across clinical programs and ensure that outcome measures generate robust evidence for both regulatory and HTA decision-making. /ph3Your responsibilities /h3ulliDevelop and lead Clinical Outcome Assessment (COA) strategies across therapeutic areas and clinical development programs /liliDefine COA plans, timelines and validation milestones for regulatory and HTA purposes /liliAdvise clinical development teams on the selection and implementation of appropriate Patient-Reported Outcomes (PROs) and other COA endpoints /liliProvide COA expertise for clinical trial protocols, statistical and psychometric analysis plans, clinical reports and related documentation /liliLead COA projects from strategy through execution in collaboration with internal stakeholders and external scientific partners /liliOversee content validation, psychometric validation and interpretation of COA results /liliEnsure that psychometric evidence meets scientific standards for regulatory submissions, product labelling and HTA dossiers /liliCollaborate closely with biostatistics, psychometrics, clinical development, data management, regulatory affairs, medical affairs and market access /liliLead or review COA analysis plans and scientific reports, ensuring a clear link between COA findings, clinical benefit and HTA requirements /liliContribute to regulatory interactions and submissions, including briefing documents, scientific advice and dossier content /liliSupport scientific publications, presentations and other evidence-generation activities /liliStay current with evolving COA methodologies, regulatory expectations and industry standards /li /ulpDepending on experience, the role may also include aligning COA endpoints with broader HEOR and HTA evidence needs, overseeing external vendors and participating in cross-functional COA governance. /ph3Your profile /h3ulliMaster's degree or PhD in Life Sciences, Psychology, Sociology, Psychometrics, Pharmacy, Biostatistics or a related scientific discipline /liliAt least 5 years of relevant experience in Health Outcomes Research, preferably within the pharmaceutical, biotechnology or consulting environment /liliProven hands-on experience in COA/PRO strategy, instrument validation and psychometric methodologies within clinical drug development is essential /liliIn-depth understanding of qualitative and quantitative COA research, instrument development, validation and interpretation /liliAbility to critically evaluate COA data and translate scientific findings into robust, regulatory-ready evidence /liliStrong understanding of global regulatory requirements and their implications for clinical outcome strategies /liliExperience with FDA and/or EMA regulatory expectations is highly desirable /liliUnderstanding of electronic COA (eCOA) implementation, including migration from paper and BYOD approaches /liliProven ability to lead complex, cross-functional projects within a global matrix organisation /liliExperience coordinating external vendors and scientific partners /liliStrong stakeholder management, communication and problem-solving skills /liliAbility to influence and collaborate effectively without direct hierarchical authority /liliProactive, collaborative and scientifically rigorous working style /li /ulh3The assignment /h3pThis is a 12-month temporary position based in Basel, starting on 1 December 2026, within an international Big Pharma environment. /ppThe role offers the opportunity to take scientific ownership of COA strategies within complex global development programs and work closely with experts across clinical development, regulatory affairs, HEOR and market access. /p